header
European Commission Calls
category MSCA
Doctoral Network Call Identifier: HORIZON-MSCA-2023-DN-01-01 MSCA Doctoral Networks 2023 HORIZON-MSCA-2023-DN-01-01

MSCA Doctoral Networks will implement doctoral programmes, by partnerships of universities, research institutions and research infrastructures, businesses including SMEs, and other socio-economic actors from different countries across Europe and beyond. Proposals for doctoral networks can reflect existing or planned research partnerships among the participating organisations. The selection procedure for doctoral candidates must be open, transparent and merit-based, in line with the Code of Conduct for the Recruitment of Researchers. MSCA Doctoral Networks are encouraged to lead to Industrial or Joint Doctorates. Industrial Doctorates: Through Industrial Doctorates, doctoral candidates will step outside academia and develop skills in industry and business by being jointly supervised by academic and non-academic organisations, both of which can be established in the same EU Member State or Horizon Europe Associated Country. Joint Doctorates: Joint Doctorates represent a highly integrated type of international, inter-sectoral and multi/interdisciplinary collaboration in doctoral training. They lead to the delivery of joint, double or multiple doctoral degrees[3] recognised in at least two EU Member States or Horizon Europe Associated Countries.


Budget: EUR 434.800.000 (single stage), 540 PM (in 2022 360 PM)
Deadline: Opening date: 30 May 2023; Deadline: 28 November 2023 17:00:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in the MSCA part of the Work Programme.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

Call Identifier: HORIZON-MSCA-2023-SE-01-01 MSCA Staff Exchanges 2023

MSCA Staff Exchanges involve organisations from the academic and non-academic sectors (including SMEs) from across the globe.
• Support is provided for international, inter-sectoral and interdisciplinary mobility of R&I staff leading to knowledge transfer between participating organisations.
• The organisations constituting the partnership contribute directly to the implementation of a joint R&I project by seconding and/or hosting eligible staff members.
• Such a project must explore activities that can be based on previous work but should go beyond and generate or strengthen long-term collaborations. Secondments must involve physical mobility of the eligible staff members and must always take place between legal entities independent from each other.
MSCA Staff Exchanges can address three dimensions of mobility: international, inter-sectoral and interdisciplinary.


Budget: EUR 78.495.000 (for year 2023)
Deadline: Opening date: 05 October 2023; Deadline: 28 February 2024 17:00:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

Call Identifier: HORIZON-MSCA-2023-COFUND-01-01 MSCA COFUND 2023

Applicants submit proposals for new or existing doctoral or postdoctoral programmes with an impact on the enhancement of human resources in R&I at regional, national or international level.
• Proposed programmes can cover any research disciplines ("bottom-up"), but exceptionally can also focus on specific disciplines, notably when they are based on national or regional Research and Innovation Strategies for Smart Specialisation (RIS3 strategies). In this case, the range of covered disciplines should allow reasonable flexibility for the researchers to define their topic.
• A Career Development Plan must be jointly established by the supervisor and each recruited researcher upon recruitment. In addition to research objectives, this Plan comprises the researcher's training and career needs, including training on transferable skills, teaching, planning for publications and participation in conferences and events aimed at opening science and research to citizens. The Plan must be established at the beginning of the recruitment and should be revised (and updated where needed) within 18 months.


Budget: EUR 96.569.000 (for year 2023)
Deadline: Opening date: 10 October 2023; Deadline: 08 February 2024 17:00:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

 


category Global Challenges and European Industrial Competitiveness
HEALTH Call Identifier: HORIZON-HLTH-2024-IND-06-08 Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)

The Medical Device Regulation (MDR) and in vitro diagnostic medical device Regulation (IVDR) provides a new regulatory framework where reinforcement of clinical/performance evaluation of medical devices and IVDs, and in particular high-risk medical devices, is a key element.

Proposals should address all of the following activities:
• Development of a framework for a life-cycle approach to evidence generation and evaluation of high-risk and innovative medical devices and IVDs.
• For medical devices, a pilot to support development of common specifications which would set the stage for a common specification ecosystem for medical devices in the EU.
• Development of a general methodological approach to define, determine and update the state of the art for different device technologies.
• Possible use of registries and other sources of real-world data for demonstration of regulatory compliance both pre- and post-market.
• Methodology for bridging studies for devices and IVDs with iterative development: assessment of data coming from previous versions of the device and where relevant integration of that data into the device’s clinical investigation/performance study and gap assessment between the different versions of the device.
• Identification of relevant quantitative and qualitative methodologies for integrating evidence derived from various data sources in the clinical evaluation/performance evaluation.


Budget: 8.000.000 to 10.000.000 EUR, indicative number of grants: 1
Deadline: Opening date: 26 October 2023; Deadline 11 April 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

HEALTH Call Identifier: HORIZON-HLTH-2024-IND-06-09 Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators

There is increasing scientific evidence pointing to the limitations of animal testing for safety and efficacy assessment of chemicals and pharmaceuticals. Europe is also experiencing a strong societal demand to move away from animal testing. Scientific progress of the past two decades has produced a number of animal-free New Approach Methodologies (NAMs) that have the potential to be used instead of the animal models that are currently employed for such testing.
The proposals should focus on alternatives to the use of animals for regulatory safety and efficacy testing. Applicants should propose activities that bring together NAM developers and NAM users with European regulators responsible for the safe use of chemicals (e.g. industrial chemicals, pesticides, biocides and cosmetics) and pharmaceuticals in order to inform on NAM solutions available and to encourage the building of a framework on how these NAMs could be most effectively used in the different decision-making contexts.


Budget: 2.000.000 EUR, indicative number of grants: 1
Deadline: Opening date: 26 October 2023; Deadline 11 April 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
The Joint Research Centre (JRC) may participate as member of the consortium selected for funding. In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding. Coordinators of projects must be legal entities established in an EU Member State or Associated Country.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-08-12 Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness

The European partnership for pandemic preparedness is working to improve the EU’s preparedness to predict and respond to emerging infectious health threats by better coordinating funding for research and innovation at EU, national (and regional) level towards common objectives and an agreed Strategic Research and Innovation Agenda.

Proposals should include all of the following activities:
• Provide an efficient secretariat for the European partnership for pandemic preparedness
• Provide administrative and organisational support to the Members in the European partnership for pandemic preparedness;
• Provide strong scientific support on topics requested by the GloPID-R Chairs, scientific advisors or (working) groups;
• Actively engage with relevant stakeholders and initiatives in the area of pandemic preparedness, ensuring collaboration and coordination, and avoiding duplication
• Implement strong communication and dissemination activities at EU level and in Member States and Associated Countries,
• Establish coordination and collaboration with relevant initiatives related to pandemic preparedness such as HERA to ensure complementarity and avoid overlaps;


Budget: 2.000.000 EUR, indicative number of grants: 1
Deadline: Opening date: 26 October 2023; Deadline 11 April 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, legal entities established in the United States of America may exceptionally participate as a beneficiary or affiliated entity, and are eligible to receive Union funding. Coordinators of projects must be legal entities established in an EU Member State or Associated Country.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

HEALTH Call Identifier: HORIZON-HLTH-2024-DISEASE-08-20 Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential

As shown by the COVID-19 pandemic, infectious diseases remain a major threat to health and health security in the EU and globally. Proposals should focus on the following viruses: Hendra and Nipah virus, Lassa virus, Crimean Congo haemorrhagic fever virus, Rift Valley fever virus, Ebola and Marburg virus, Dengue virus, Yellow Fever virus, Zika virus, West Nile fever virus and Chikungunya virus.

Proposals should address several of the following areas:
• Identification and characterisation of receptors on the host cell that enable the docking and internalisation of a virus with a particular emphasis on the diversity of cellular entry receptors and tissue specificity.
• Identification and characterisation of viral surface proteins that are capable of interacting with host target cells.
• Characterisation of the mechanism of viral uptake in the host cell with regard to the topology and the dynamics of the host receptor – virus ligand interaction.
• Identification of receptor and ligand (sub)units that could be targeted by preventive or therapeutic intervention.


Budget: 7.000.000 to 8.000.000 EUR, indicative number of grants: 5
Deadline: Opening date: 26 October 2023; Deadline 11 April 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding. The Joint Research Centre (JRC) may participate as member of the consortium selected for funding.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

HEALTH Call Identifier: HORIZON-HLTH-2024-TOOL-11-02 Bio-printing of living cells for regenerative medicine

Despite some success of 3D bio-printing with thin tissue, thick tissue and complex organs remain a bottleneck because it is difficult to sufficiently mimic their metabolic needs, and the scientific knowledge about their intimate architecture and interplay with other tissues are not sufficiently elucidated.

Proposals should address most of the following activities:
• Design the best bio-printing strategy for at least one type of tissue thanks to a better understanding of the interconnections of the different cell types inside the chosen tissue or organ
• Develop or improve existing equipment able to print bio-constructs with higher resolution in a shorter time using various biomaterials and different cell types
• Cover all steps of the bio-printing suite, including cell collection, cell differentiation and expansion, imaging, modelling, bio-ink formulation, actual bio-printing, nutrient supply, process monitoring and cell-construct delivery at target site
• Scale-up the chosen bio-printing technology to a GMP-conform manufacturing process
• Combine different bio-printing technologies in order to obtain fully functional synthetic constructs of complex tissues or organs.


Budget: 6.000.000 to 8.000.000 EUR, indicative number of grants: 4
Deadline: Opening date: 26 October 2023; Deadline 11 April 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries: described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

HEALTH Call Identifier: HORIZON-JU-IHI-2023-05-01 Accelerating the implementation of New Approach Methodologies and other innovative non-animal approaches for the development, testing and production of health technologies

Animals and animal-derived materials are widely used in biomedical research and in the production and development of health technologies. This raises serious ethical concerns, and there is growing societal pressure to move towards alternative approaches and methods.
• NAMs and other innovative non-animal approaches have high potential to improve the development and/or production of health technologies, while contributing to the reduction and replacement of the use of animals.
• While the potential for using non-animal approaches for the production, development and testing of new health technologies is enormous, more evidence and high-quality data for their performance evaluation in comparison with established animal-based approaches for a specific application and for their validation are required by the industry and regulators to implement these alternative approaches in R&D and decision‑making processes.
• In addition, policy makers require a large body of up-to-date, high-quality knowledge to inform relevant health policies and ensure the long-term goal of full transition to non-animal approaches. The current topic seeks to address these challenges by exploiting the latest relevant scientific advancements to develop NAMs and other non-animal approaches, which could be more readily available and more efficient than those involving animals, and which should improve either the development, including efficacy and safety assessment, of new health technologies for infectious/non-communicable diseases or the production processes of such technologies.


Budget: around 10.000.000 to 12.000.000 EUR, with approx. indicative number of grants/topics: 2
Deadline: Opening date: 27 July 2023; Deadline 16 January 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- for a single-stage Call, the limit for RIA full proposals is 50 pages

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

HEALTH Call Identifier: HORIZON-JU-IHI-2023-05-02 Development and proof of principle of new clinical applications of theranostics solutions

Multi-modal theranostic solutions, currently dominated by radionuclide-based therapy and companion diagnostics, are emerging as safe, personalised, and effective approaches for the treatment of several diseases.

Project(s) funded under this topic should aim at:
• Developing new, or innovative combinations of existing multi-modal theranostic solutions including radiopharmaceuticals and/or non- radioactive theranostic solutions.
• Applicants should clearly identify a disease(s) of unmet public health need, (e.g., oncology, neurology and/or advanced multi-disease conditions) and explain their choice with relevant evidence where possible.
• Develop tools for the quantification of the chosen disease(s) through the development of novel modalities to ensure proper planning and monitoring of patient care, which may include imaging, artificial intelligence and pathology models;
• Facilitate the development of tools to increase European theranostic manufacturing capabilities and treatment capacities, including guidance on quality assurance and improving logistics of supply at the EU level;
• Develop education and training materials on the deployment of multi-modal theranostic solutions and their integration in clinical settings including recommendations for the organisation and composition of disease-specific medical expert boards.


Budget: around 10.000.000 to 12.000.000 EUR, with approx. indicative number of grants/topics: 2
Deadline: Opening date: 27 July 2023; Deadline 16 January 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- for a single-stage Call, the limit for RIA full proposals is 50 pages

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

HEALTH Call Identifier: HORIZON-JU-IHI-2023-05-03 Improved prediction, detection, and treatment approaches for comprehensive stroke management

Globally, stroke is the second leading cause of death and the third leading cause of disability. One in four people are in danger of stroke in their lifetime.
• The implementation of connected healthcare pathways will lead to an improvement in the outcome for the patients and thereby drive efficiency and effectiveness from a clinical and health resource perspective.
• Integrating data is key to allow for modelling, artificial intelligence (AI) and machine learning (ML)-based evaluation to identify groups and individual persons at risk and assure early recognition of stroke.
• Comprehensive stroke management continues in the post-acute treatment setting and includes long-term follow-up for secondary prevention and rehabilitation.
• Innovative solutions for faster acquisition, integration, and better retention of multiple types of data and better organisation among the various actors across the entire stroke pathway are crucial to achieve optimal prevention and treatment focused on the needs of patients.


Budget: around 10.000.000 to 12.000.000 EUR, with approx. indicative number of grants/topics: 2
Deadline: Opening date: 27 July 2023; Deadline 16 January 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- for a single-stage Call, the limit for RIA full proposals is 50 pages

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

HEALTH Call Identifier: HORIZON-JU-IHI-2023-05-04 Maximising the potential of synthetic data generation in healthcare applications

Healthcare research using individual patient data is often constrained due to restrictions in data access because of privacy, security, intellectual property (IP) and other concerns. However, while many synthetic data generation (SDG) methods are currently available, it is not always clear which method is best for which use case, and SDG methods for some types of data are still immature.

Projects funded under this topic should address the following objectives:
• Assemble a cross-sectoral public-private consortium including synthetic data experts, public and private data owners, and healthcare solution developers; using high-quality public and private datasets, develop / further develop and validate reliable SDG methods for relevant healthcare use cases.
• The use cases to be explored must be described and justified in the proposal, complement work that is already ongoing, and should: (i) ensure the broad applicability of the SDG methods developed and include data types that are not currently adequately addressed, such as device data, image data, genomic data etc;
(ii) include methods to generate: a) fully synthetic datasets that do not contain any real data; b) hybrid datasets composed of a combination of data derived from both real and synthetic data; and c) synthetically-augmented datasets.
(iii) validate the synthetic data generation methods applied in the project using source data. This should include assessing the risk of re-identification;
(iv) demonstrate the quality and applicability of the synthetic data generated in the project through the development of relevant models;


Budget: around 10.000.000 to 12.000.000 EUR, with approx. indicative number of grants/topics: 2
Deadline: Opening date: 27 July 2023; Deadline 16 January 2024 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- for a single-stage Call, the limit for RIA full proposals is 50 pages

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

HEALTH Call Identifier: HORIZON-JU-IHI-2023-04-02-two-stage Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare

The overall aim of the project generated from this topic is to create and validate the infrastructure and logistics for blood collection by the patient and/or caregiver at home as a healthcare tool and an alternative to the current gold standard venous blood for routine clinical assays. This project will employ only commercially available CE-marked microsampling devices, according to their intended use.
The development of new devices for blood sampling or of new clinical assays / analytes is not the focus of this project, and no new clinical assays will be evaluated. Similarly, given their current maturity, home sample analysis is out of scope.
Training materials, customised for patients and caregivers as well as for medical personnel will be developed, ensuring the acceptability of the new approach to these groups. Interactions with regulatory authorities, the European Medicines Agency (EMA), local European agencies as well as regulatory agencies from non-EU European countries and the US Food and Drug Administration (FDA) will be sought to advance the regulatory acceptability of the logistics model and harmonisation across the EU, other non-EU European countries and the US.


Budget: around 4.500.000 EUR with approx. indicative number of grants/topics: 1
Deadline: Opening date: 27 July 2023; Deadline 08 November 2023 (1st stage) 23 April 2024 (second stage) 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- at stage 1 of a two-stage Call, the limit for RIA short proposals is 20 pages;
- at stage 2 of a two-stage Call, the limit for RIA full proposals is 50 pages.

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

HEALTH Call Identifier: HORIZON-JU-IHI-2023-04-03-two-stage Inclusive clinical studies for equitable access to clinical research in Europe

Patient recruitment and retention remains a leading challenge in the efficient completion of clinical studies, including studies on medicinal products, medical devices, or IVDs. Furthermore, despite advancement of enrolment practices designed to better reflect the population most likely to use the health technologies in clinical practice, there is still only limited diversity within recruited patient populations. The under-representation of diverse populations (due for instance to their race and ethnicity, gender, age, socio-economic status, geographical location) creates knowledge gaps about the risks and benefits of health technologies for these specific populations.
This topic aims to develop a multi-faceted, intersectional approach to overcome the multifactorial barriers associated with the recruitment and retention of underserved patient populations in clinical studies and to contribute to transforming the way clinical studies are conducted in Europe.


Budget: around 4.500.000 EUR with approx. indicative number of grants/topics: 1
Deadline: Opening date: 27 July 2023; Deadline 08 November 2023 (1st stage) 23 April 2024 (second stage) 17:00 Brussels time
Who can apply: 1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System
- at stage 1 of a two-stage Call, the limit for RIA short proposals is 20 pages;
- at stage 2 of a two-stage Call, the limit for RIA full proposals is 50 pages.

2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes and in the ''Conditions of the Calls for proposals and Calls management rules'' section of the IHI JU Work Programme (WP)

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes

 


category Innovative Europe
The European Innovation Council (EIC) EIC Pathfinder Challenge - Precision nutrition


Budget: Budget/project: up to 4 EUR million; Total budget topic: 163.5 EUR million
Deadline: Opening date: 20 June 2023 Deadline: 18 October 2023, 17:00 (CEST)
Who can apply: Challenge_Guide2023_Precision_nutrition_final.pdf

 


category Excellent Science
European Research Council (ERC) ERC STARTING GRANTS

Who can apply: Researchers of any nationality with 2-7 years of experience since completion of PhD, a scientific track record showing great promise and an excellent research proposal can apply.


Budget: 1.500.000 EUR for 5 years (pro rata for projects of shorter duration). Indicative number of grants: 387.
Deadline: Opening date: 11 July 2023 Deadline: 24 October 2023, 17:00 (CEST)
Who can apply: https://erc.europa.eu/apply-grant/starting-grant

European Research Council (ERC) ERC SYNERGY GRANTS

Who can apply: A group of two to maximum four Principal Investigators (PIs) working together and bringing different skills and resources to tackle ambitious research problems. One will be designated as the corresponding PI (cPI).
No specific eligibility criteria regarding the academic training are foreseen for ERC Synergy Grants.
PIs must present an early achievement track-record or a ten-year track-record, whichever is most appropriate.
Proposals are evaluated on the sole criterion of scientific excellence which takes on the additional meaning of outstanding intrinsic synergetic effect.


Budget: max. 10.000.000 EUR (an additional € 4 million can be requested). Indicative number of grants: 39.
Deadline: Opening date: 12 July 2023 Deadline: 08 November 2023, 17:00 (CEST)
Who can apply: https://erc.europa.eu/apply-grant/synergy-grant
header
Other Calls
header
National Calls
Finanziamenti MISE
Trasformazione Digitale delle PMI Digital Transformation


Budget: Le risorse finanziarie per la concessione delle agevolazioni ammontano a euro 100.000.000,00
Deadline: Data chiusura: 31 Dicembre 2023 (aperto fino ad esaurimento risorse)
Who can apply: Possono beneficiare delle agevolazioni le PMI che, alla data di presentazione della domanda, risultino;

iscritte come attive nel Registro delle imprese;
operano in via prevalente o primaria nel settore manifatturiero e/o in quello dei servizi diretti alle imprese manifatturiere e/o nel settore turistico e/o nel settore del commercio;
hanno conseguito, nell'esercizio cui si riferisce l'ultimo bilancio approvato e depositato, un importo dei ricavi delle vendite e delle prestazioni pari almeno a euro 100.000,00;
dispongono di almeno due bilanci approvati e depositati presso il Registro delle imprese;
non sono sottoposte a procedura concorsuale e non si trovano in stato di fallimento, di liquidazione anche volontaria, di amministrazione controllata, di concordato preventivo o in qualsiasi altra situazione equivalente secondo la normativa vigente.

Le PMI in possesso dei predetti requisiti possono presentare, anche congiuntamente tra loro, purché in numero comunque non superiore a dieci imprese, progetti realizzati mediante il ricorso allo strumento del contratto di rete o ad altre forme contrattuali di collaborazione, compresi il consorzio e l’accordo di partenariato in cui figuri, come soggetto promotore capofila, un DIH-digital innovation hub o un EDI-ecosistema digitale per l’innovazione, di cui al Piano nazionale Impresa 4.0.

Settori: Agroalimentare, Moda e Tessile, Chimica e Farmaceutica, Metallurgia, Elettronica, Meccanica, Autoveicoli e altri mezzi di trasporto, Mobili, Legno e Carta, Edilizia, Fornitura Energia, Acqua e gestione Rifiuti, Commercio, Servizi di trasporto, Alberghiero, Ristorazione, ICT, Cultura, Turismo, Salute, Altri servizi, Artigianato.

 


Finanziamento IKIGAI - FMPS
Finanziamento di progetti individuali BANDO IKIGAI 2022 – 2024


Budget: Il bando sarà gestito con la collaborazione tecnica di Pluriversum Srl, società identificata dalla Fondazione come partner del progetto in virtù della consolidata conoscenza regionale di promozione e sostegno all’occupazione della società.

Per le modalità di erogazione e di partecipazione alle misure si rimanda agli specifici bandi e call che saranno pubblicati sui canali di comunicazione di IKIGAI (sul sito ikigaihub.it e sulle pagine social di IKIGAI), sui canali di comunicazione di Fondazione MPS (fondazionemps.it e ikigai.fondazionemps.it) e sulle comunicazioni a stampa.

Deadline:
Who can apply:

Call Identifier: Not yet available


Budget:
Deadline:
Who can apply:

 

 

 

 

 

   


Innovation Acta S.r.l. | Via delle Province, 1 - 53100 Siena - Italy | VAT number: 13201341008

© 2020 Innovation Acta - All rights reserved

PRIVACY

Innovation Acta S.r.l.
VAT number: 13201341008

+39 0577 1652729
  +39 366 3746125

  info@innovationacta.eu
  acta_srl@pec.it

Registered office and operational headquarter:
Via delle Province, 1 - 53100 Siena - Italy


Branch office:
Via D.A. Azuni, 9 - 00196 Roma - Italy